Crizac is an asset-light B2B marketplace for international student recruitment, connecting counselling agents with universities and earning a commission from the university on each enrolled student. It sits between more than 17,400 counselling partners and over 450 university partners across 12 destination markets and more than 85 source countries, with the United Kingdom contributing roughly 97% of revenue. The economics are attractive: FY26 revenue was INR 10,422 million, up 22.7%, with EBITDA of INR 2,824 million at a 27% margin, PAT of INR 2,191 million up 41%, ROCE of 48.6%, and a debt-free balance sheet holding INR 5,695 million of net cash as of June 2026. A sustained EBITDA margin near 27% to 30% on a commission model with minimal working capital signals genuinely high-quality unit economics rather than a pass-through agency.
The moat rests on compliance depth and network stickiness rather than exclusivity. Crizac represents more than 95 of the roughly 100 commercial universities in the UK, its student visa refusal rate runs well below the UKVI 5% threshold, and the UK Agent Quality Framework plus Australia's tightening national codes push universities toward fewer, larger, compliant platforms, which management argues increases pricing power. Agents typically work with one or two platforms and none have left, while the top 30 university partners have relationships exceeding five years. That said, there is no exclusivity on either side, most universities work with multiple platforms, and entry into other English-speaking destinations is hard: a US expansion attempted three years ago failed against restrictive visa policy, so the barrier is real in the UK and Ireland, where Crizac holds close to 10% share, but unproven elsewhere.
The inflection now underway is geographic and regulatory, not demand-led. The August 2026 call guided FY27 to be broadly flat versus FY26, with Q2 hurt by February-to-June international travel disruption and recovery expected in Q3 and Q4 on healthy application flow already visible. Over the next 18 to 24 months the shape of the business changes through small, cheap acquisitions: Medway operationalized New Zealand at scale in April 2026 with all NZ institutions represented, Innova added Mexico sourcing and the Netherlands destination for under INR 7 crores, and ForeignAdmits in June 2026 extends into education financing and visa preparation, targeted to add 2% to 5% to EBITDA and 1% to 1.5% of revenue over the next couple of years. Australia recruiting was slated to begin within three to six months of May 2026 pending multi-year university contracts. Management targets UK concentration below 60% within three years, meaning by roughly FY29 the platform should carry materially lower single-country risk, though FY27 itself is a pause year.
The walk-talk record shows delivery on profit but repeated trimming of growth ambition. In October 2025 management guided FY26 revenue growth of 25% to 30% and delivered 22.7%, a modest miss; it promised to exceed FY25 PAT of INR 155 crores and delivered INR 219 crores, a clear beat. In January 2026 it projected 20% to 25% growth over five years; by May 2026 the FY27 guide was 15% to 17%, and by August 2026 that became flat, while the UK-below-60% target slipped from two years to three. Capital allocation remains conservative: acquisitions under INR 10 crores each funded from cash, a 64% dividend payout in FY26 against a committed 40% minimum for at least two more years, and a promoter stake near 80% with dilution contemplated before the 75% SEBI threshold.
The quantified path is a flat FY27 at 25% to 27% EBITDA margin followed by reacceleration as pent-up demand and new geographies convert, with Q1 FY27 already showing the tension that defines the thesis: enrollment grew 15% year-on-year yet constant-currency revenue fell about 4% because a shifted university mix caused missed bonuses and slabs from top-ranked institutions, and the top 3 universities contributed 41% of quarterly revenue. This is a mix and realization problem, not a demand collapse, since application volumes remain robust. The single falsifier to watch is the Q3 and Q4 FY27 intake: if the promised recovery does not materialize, or if UK policy tightens further after the graduate route shortens to 18 months from January 2027, the diversification timeline stretches and the flat year becomes structural rather than cyclical.
companyname: Crizac Limited ticker: CRIZAC sector: Education Technology / International Student Recruitment Crizac is a B2B, AI-native student mobility platform that connects counselling agents to universities and processes student applications end-to-end. Founded in 2011 in Calcutta, the company operates a proprietary technology platform that today connects more than 17,400 counselling partners with over 450 university partners across 12 destination markets and more than 85 source markets. As ...
Read the full report →regulatory approval, new product segment, geographic expansion, acquisition inorganic
No guidance
Guidance no_dataconsistent
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Crizac Ltd. and 4,900+ companies.
5-day free pass. No card required.